Solvent/polymer solutions as suspension vehicles
View Patent ↗A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be selected from the group consisting of benzyl benzoate, decanol, ethyl hexyl lactate, and mixtures thereof and the at least one polymer may be selected from the group consisting of a polyester, pyrrolidone, ester of an unsaturated alcohol, ether of an unsaturated alcohol, polyoxyethylenepolyoxypropylene block copolymer, and mixtures thereof. In one embodiment, the at least one solvent is benzyl benzoate and the at least one polymer is polyvinylpyrrolidone. A stable, nonaqueous suspension formulation that includes the nonaqueous, single-phase vehicle and an active agent, and a method of forming the same, are also disclosed.
1. A method for detecting at least one air bubble in at least one component of an implantable osmotic drug delivery device, wherein the implantable osmotic drug delivery device comprises a suspension formulation, a semipermeable membrane, an osmotic engine, a piston, a diffusion moderator, and a reservoir, the reservoir comprising titanium, the method comprising:
X-raying the implantable osmotic drug delivery device under conditions sufficient to detect the at least one air bubble if present, so as to determine or verify prior to implantation of the implantable osmotic drug delivery device, during a period of implantation of the implantable osmotic drug delivery device, or after explantation of the implantable osmotic drug delivery device at least one of:
stability of the suspension formulation; and
integrity of the implantable osmotic delivery device.
2. The method of claim 1 , wherein the at least one component of the implantable osmotic drug delivery device comprises the suspension formulation.
3. The method of claim 1 , wherein the at least one component of the implantable osmotic drug delivery device comprises the osmotic engine.
4. The method of claim 1 , wherein the at least one component of the implantable osmotic drug delivery device comprises the diffusion moderator.
5. The method of claim 1 , wherein the at least one component of the implantable osmotic drug delivery device comprises the reservoir.
6. The method of claim 1 , wherein the integrity of the implantable osmotic delivery device is indicative of whether the implantable osmotic delivery device will deliver or has delivered the suspension formulation at a controlled rate without blocking or occluding the implantable osmotic delivery device.
7. The method of claim 1 , wherein the stability of the suspension formulation is indicative of whether the suspension formulation will maintain or has maintained stability over an extended period of time.
8. A method for detecting a position of a piston in an implantable osmotic drug delivery device relative to the implantable osmotic drug delivery device, the implantable osmotic drug delivery device comprising a suspension formulation, a semipermeable membrane, an osmotic engine, a piston, a diffusion moderator, and a reservoir, the reservoir comprising titanium, the method comprising:
X-raying the implantable osmotic drug delivery device under conditions sufficient to detect the position of the piston relative to the implantable osmotic drug delivery device, so as to determine or verify integrity of the implantable osmotic delivery device prior to implantation of the implantable osmotic drug delivery device, during a period of implantation of the implantable osmotic drug delivery device, or after explantation of the implantable osmotic drug delivery device.
9. The method of claim 8 , wherein the position of the piston is detected after the device is explanted from an animal.
10. The method of claim 9 , wherein the animal is a human.
11. A method for imaging one or more contents of an implantable osmotic drug delivery device, the implantable osmotic drug delivery device comprising a suspension formulation, a semipermeable membrane, an osmotic engine, a piston, a diffusion moderator, and a reservoir, the reservoir comprising titanium, the method comprising:
N-raying the implantable osmotic drug delivery device under conditions sufficient to image the one or more contents of the implantable osmotic drug delivery device, so as to determine or verify prior to implantation of the implantable osmotic drug delivery device, during a period of implantation of the implantable osmotic drug delivery device, or after explantation of the implantable osmotic drug delivery device at least one of:
stability of the suspension formulation; and
integrity of the implantable osmotic drug delivery device.
12. The method of claim 11 , wherein the integrity of the implantable osmotic delivery device is indicative of whether the implantable osmotic delivery device will deliver or has delivered the suspension formulation at a controlled rate without blocking or occluding the implantable osmotic delivery device.
13. The method of claim 11 , wherein the stability of the suspension formulation is indicative of whether the suspension formulation will maintain or has maintained stability over an extended period of time.
14. The method of claim 11 , wherein the determining or the verifying the integrity of the implantable osmotic delivery device comprises determining or verifying whether the semipermeable membrane is intact.
15. The method of claim 11 , wherein the determining or the verifying of the integrity of the implantable osmotic delivery device comprises detecting a position of the piston in the implantable osmotic drug delivery device relative to the implantable osmotic drug delivery device.
16. The method of claim 11 , further comprising detecting at least one of:
an air bubble in at least one component of the implantable osmotic drug delivery device by N-ray; and
detecting a position of the piston in the implantable osmotic drug delivery device relative to the implantable osmotic drug delivery device.
17. A method for characterizing stability or integrity of at least one component of an implantable osmotic drug delivery device, wherein the implantable osmotic drug delivery device comprises a suspension formulation, a semipermeable membrane, an osmotic engine, a piston, a diffusion moderator, and a reservoir, the reservoir comprising titanium, the method comprising:
X-raying the implantable osmotic drug delivery device under conditions sufficient to detect at least one of:
at least one air bubble in the at least one component of the implantable osmotic drug delivery device; and
a position of the at least one component of the implantable osmotic drug delivery device relative to the implantable osmotic drug delivery device, so as to determine or verify prior to implantation of the implantable osmotic drug delivery device, during a period of implantation of the implantable osmotic drug delivery device, or after explantation of the implantable osmotic drug delivery device at least one of:
stability of the suspension formulation; and
integrity of the at least one component of the implantable osmotic delivery device.